(firstQuint)A Study to Test the Safety/Tolerability of Increasing Doses of LNP1892 Versus Placebo in Healthy Male/Female Subjects.

 This is first in human, Phase 1 study.

 Primary purpose is to assess safety, tolerability, pharmacodynamic and pharmacokinetic of the LNP1892.

 Study will be conducted in healthy human subjects.

 Pharmacokinetic will be studied in the subjects after administration of single and multiple doses.

.

 A Study to Test the Safety/Tolerability of Increasing Doses of LNP1892 Versus Placebo in Healthy Male/Female Subjects@highlight

The purpose of this study is to determine the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple ascending oral dose LNP1892 in healthy males and female subjects